毒素A型对于大耳神经疼痛
Yan Tereshko1, Christian Lettieri2, Enrico Belgrado2
1Clinical Neurology Unit, Department of Neuroscience, Udine University Hospital, Piazzale Santa Maria Della Misericordia 15, 33100, Udine, Italy.
概括
大耳神经疼痛是一种罕见的疾病,在A型肉毒素注射后,有显著的疼痛缓解. 需要进一步的研究来确认这种对大耳神经疼痛的潜在治疗方法.
科学领域:
- 神经学 神经学
- 疼痛医学 医学 疼痛医学
背景情况:
- 大耳神经疼痛是一种非常罕见的疾病,记录的病例有限.
- 目前的治疗策略缺乏基于证据的建议,依赖于事案例报告.
研究的目的:
- 为了研究毒素A型作为治疗大耳神经疼痛的疗效.
主要方法:
- 一个案例研究详细介绍了大耳神经疼痛的治疗方法,使用甲型玻尿素毒素的皮下注射.
主要成果:
- 患者经历了一种显著的减轻疼痛后,肉毒素A型治疗.
- 观察到治疗是安全和有效的管理大耳神经疼痛的症状.
结论:
- 甲型玻尿素毒素为大耳神经疼痛提供了一个有希望和安全的治疗选择.
- 需要进一步的临床研究来验证这些发现,并制定最终的治疗指南.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
711
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
711
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
479
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
479
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K


